HeatherAlisonJaceneMD
Nuclear Medicine • Boston, MAAssistant Professor of Radiology, Brigham and Women's Hospital
Dr. Jacene is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
# Radiolog
Boston, MA 02115Phone+1 617-632-3767Fax+1 617-525-7333
Education & Training
Johns Hopkins UniversityResidency, Nuclear Medicine, 2002 - 2003
Jersey Shore University Medical CenterInternship, Internal Medicine, 2001 - 2002
Rutgers Robert Wood Johnson Medical SchoolClass of 2001
Certifications & Licensure
MA State Medical License 2010 - 2026
MD State Medical License 2004 - 2016- American Board of Nuclear Medicine Nuclear Medicine
Clinical Trials
- Safety and Efficacy Study of I-131 Tositumomab in Patients With Relapsed/Refractory Hodgkin's Lymphoma Start of enrollment: 2007 Jun 01
- A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma Start of enrollment: 2008 Aug 01
- Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy Start of enrollment: 2015 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 15 citationsRadionuclide Therapy for Osseous Metastases in Prostate CancerAlain S. Abi-Ghanem, Mary A. McGrath, Heather A. Jacene
Seminars in Nuclear Medicine. 2015-01-01 - 6 citationsOvercoming differential tumor penetration of BRAF inhibitors using computationally guided combination therapy.Thomas S C Ng, Huiyu Hu, Stefan Kronister, Chanseo Lee, Ran Li
Science Advances. 2022-04-29 - 35 citationsSNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors.Thomas A Hope, Martin Allen-Auerbach, Lisa Bodei, Jeremie Calais, Magnus Dahlbom
Journal of Nuclear Medicine. 2023-02-01
Press Mentions
SNNMI Abstract of the Year: Targeted Radionuclide Treatment Achieves High Response Rate, Minimal Toxicities for Advanced-Stage Neuroendocrine TumorsJune 15th, 2022- ‘Image of the Year’ Highlights the Predictive Power of a New PET Imaging AgentJune 15th, 2022
- SNMMI Image of the Year: New Biomarker Predicts Severity of Cardiac Remodeling After Heart AttackJune 14th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
